CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- SC 13G/A Stake Amended Statement of Ownership
- 4 Planned sale Chief Financial Officer sold 3,178 shares at $9.70 ($30,827)
- 4 Grant or award Chief Marketing Officer acquired 63,358 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale See Remarks sold 2,211 shares at $10.27 ($22,707)
- 4 Planned sale Chief Financial Officer sold 2,211 shares at $10.27 ($22,707)
- 4 Planned sale See Remarks sold 14,778 shares at $10.27 ($151,770)
- 4 Open-market buy Director bought 174,967 shares at $7.41 ($1,296,505)
- 4 Other acquisition Director acquired 115,315 shares (other)
- 4 Other acquisition Director acquired 584 shares (other)
- SC 13D/A Stake Beneficial Ownership Report
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Results of operations
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Bylaws or fiscal year change · Shareholder vote results
- 424B5 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
Page 10 of 28 · 558 filings